SCHEMBL5404946

SCHEMBL5404946

Fc1cccc(Cc2cc(Cl)ncn2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.40
GPR52 Q9Y2T5 1/20 0.39
ADCY10 Q96PN6 2/20 0.39
IDO1 P14902 2/20 0.39
AGXT P21549 2/20 0.39
CLK4 Q9HAZ1 2/20 0.38
DAO P14920 1/20 0.38
CCNT1 O60563 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
CDC7 O00311 1/20 0.37
DBF4 Q9UBU7 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
JAK2 O60674 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
PAK4 O96013 1/20 0.37
ABL1 P00519 1/20 0.37
LCK P06239 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931712 0.86 TAAR1 (0.46) TAAR1IDO1AGXTCLK4DAO
SCHEMBL31749981 0.83 GPR52 (0.33) GPR52IDO1
SCHEMBL5400082 0.81 HSP90AB1 (0.41) ADCY10IDO1DAOCNR1CNR2
SCHEMBL7776064 0.81 HTR2B (0.46) TAAR1GPR52IDO1DAOCDC7
SCHEMBL31750237 0.81 HTR2B (0.46) TAAR1GPR52IDO1DAOCDC7
SCHEMBL3913251 0.81 ALDH1A1 (0.52) CLK4
SCHEMBL5591246 0.79 ADCY10 (0.45) TAAR1ADCY10IDO1AGXTDAO
SCHEMBL5479186 0.77 ALDH1A1 (0.46) TAAR1ADCY10IDO1AGXTCLK4
SCHEMBL5404827 0.77 PKM (0.38) TAAR1DAOKDM4EKDRERBB2
SCHEMBL29442786 0.75 ALDH1A1 (0.64) TAAR1ADCY10IDO1AGXTDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100415725-C Pyrimidine compound and application thereof SUMITOMO CHEMICAL CO (JP) 2008-09-03 CN disclosed
US-7291730-B2 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-06 US disclosed
US-7291730-B2 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-06 US disclosed
US-7291730-B2 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-06 US disclosed
US-20050107609-A1 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY 2005-05-19 US disclosed
US-6838463-B2 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-01-04 US disclosed
EP-1366026-B1 PYRIMIDINE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2004-12-01 EP disclosed
US-20040077669-A1 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-22 US disclosed
CN-1478082-A Pyrimidine compound and application thereof ס�ѻ�ѧ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1366026-A2 PYRIMIDINE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2003-12-03 EP disclosed
WO-2002024663-A2 PYRIMIDINE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107609-A1 Pyrimidine compounds and their use TYMP, TYMS, UMPS TAAR1 1292/4885GPR52 1175/4885ADCY10 1324/4885
US-20040077669-A1 Pyrimidine compounds and their use TYMP, TYMS, DPYD TAAR1 2360/4885GPR52 2482/4885ADCY10 2784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.